NanoString Technologies reported having 766 employees as of 2021.
NanoString Technologies is a biotechnology company specializing in developing, manufacturing, and marketing products for gene expression analysis. Understanding the size and scope of such an organization is crucial, and the employee count serves as a key indicator of its operational scale, resource allocation, and overall capacity in the dynamic biotech industry.
For a clearer perspective on NanoString Technologies' operational scale in 2021, here are some key figures:
| Metric | Value (2021) |
|---|---|
| Number of Employees | 766 |
| Revenue | $144.0 million |
| Net Income | -$80.1 million |
| Total Equity | $479.5 million |
| Company Type | Public |
This employee count represents the workforce dedicated to various critical functions, including cutting-edge research and development, efficient manufacturing processes, global sales and marketing efforts, and essential administrative support. As with any growing public company, the number of employees can evolve over time, influenced by factors such as strategic growth initiatives, market demands, or organizational restructuring. The 2021 figure provides a definitive benchmark for the company's size during that period, reflecting its commitment to advancing genomics research and clinical diagnostics.
